Brief: Crossject H1 net loss shrinks to 2.8 mln euros
Sept 16 (Reuters) - Crossject SA ALCJ.PA :
* H1 operating revenue 1.6 million euros ($17.84 million) versus 1.2 million euros year ago
* H1 net loss 2.8 million euros versus loss of 3.6 million euros year ago
* H1 operating loss 2.8 million euros versus loss of 3.8 million euros year ago
Source text for Eikon: ID:nGNE4DQT0S
Further company coverage: ALCJ.PA
($1 = 0.8966 euros)
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))
Recent news on Crossject SA
See all newsBrief: Crossject Says Expects To File For EUA Early Next Year For Epilepsy Rescue Therapy Zepizure
Brief: Crossject Signs A Geographic Extension Of Zepizure Commercialization Agreement In Europe
Brief: Crossject FY Operating Income Up At EUR 12.82 Mln
Brief: Crossject Announces Contract Of Up To $155 Mln With BARDA
Brief: Crossject Engages Syneos Health For U.S. Commercial Launch Of Zepizure